Scroll Up
Scroll Down
Play Play Play Play
DG logo
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Multiple Sclerosis

The latest medical news and information for patients or friends/parents of patients diagnosed with Multiple Sclerosis.

Medical News and Alerts
Multiple Sclerosis Information
Discussion Groups and Newsgroups
Other Related Sites


Medical News and Alerts

Patients' Multiple Sclerosis Lesion Type Dictates Effective Treatment
FDA Approves Dalfampridine to Improve Walking in Adults With MS
Low Vitamin D Levels Associated With Greater Risk of Relapse in Childhood-Onset Multiple Sclerosis
Interferon Beta-1b Approved in China for Multiple Sclerosis
Women With MS No More Likely to Have Pregnancy Complications Than General Population
MS More Aggressive in Children but Slower to Cause Disability Than in Adults
Experimental Drug Reduces Pseudobulbar Affect in Patients With MS, ALS: Presented at ANA
Glatiramer Acetate Treatment Reduces Risk of Early MS Progressing to Clinically Definite Disease
Fampridine Sustained-Release Tablets Beneficial as Long-Term Therapy for Patients With MS: Presented at EFNS
FDA Continues to Receive Reports of PML in Patients Receiving Natalizumab

More news>>>



Multiple Sclerosis Information
Discussion Groups and Newsgroups
Other Related Sites
All comments and feedback are appreciated. We regret however that we cannot provide responses regarding a medical diagnosis, treatment, drug availability or pricing.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.


All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.